Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 11 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

11 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 25, 2019 CC S 10,000 $38.66 $386,600 73,562 Direct -11.97% Disposed -64.5% (price as of 2026-10-02)
Feb. 20, 2018 CC S 13,770 $50.01 $688,638 49,323 Direct -21.82% Disposed -72.6% (price as of 2026-10-02)
June 5, 2017 CC S 19,036 $41.42 $788,471 49,323 Direct -27.85% Disposed -66.9% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
March 5, 2019 CC Stock Option (Right to Buy) Common Stock (27,874) $38.02 March 1, 2029 27,874 Acquired
March 1, 2018 CC Stock Option (Right to Buy) Common Stock (17,518) $48.53 March 1, 2028 17,518 Acquired
Feb. 20, 2018 CC Common Stock Common Stock (13,770) $8.80 May 31, 2026 13,770 Disposed
March 9, 2017 CC Stock Option (Right to Buy) Common Stock (23,746) $34.72 Feb. 28, 2027 23,746 Acquired
June 1, 2016 CC Stock Option (Right to Buy) Common Stock (41,308) $8.80 May 31, 2026 41,308 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CC

President, Fluoroproducts
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2017 $550,000 · $619,787 $359,989 $825,000 · $345,674 $2,700,450
2016 $320,833 $650,000 $969,558 $240,000 $701,250 · $53,668 $2,935,309
2015 · · · · · · · ·

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.